Risk of death at five years is lower for aneurysm patients treated with coil embolization compared to surgical clipping NATICK, Mass., May 26 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) today welcomed publication of results from the …
Devices, Interventional, Neurology
Boston Scientific, coil embolization, GDC Coils, aneurysm, ISAT data

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Boston Scientific Welcomes Results of Brain Aneurysm Medical Trial”
Leave a Comment